Grapes and human health: A perspective

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 16, 2008, Pages 6777-6784

  Pezzuto, John M ^a  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

Chemoprevention; Disease prevention; Grapes; Phytochemicals; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; RESVERATROL; STILBENE DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL; BLADDER DISEASE; CHEMISTRY; DIET; FRUIT; GRAPE; HEALTH PROMOTION; HUMAN; REVIEW;

ALZHEIMER DISEASE; ANIMALS; ANTICARCINOGENIC AGENTS; DIET; FRUIT; HEALTH PROMOTION; HUMANS; STILBENES; URINARY BLADDER DISEASES; VITIS;

VITACEAE;

EID: 51649111023     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800898p     Document Type: Review

References (101)

1. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W. W.; Fong, H. H. S.; Famsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
2. Pezzuto, J. M.; Kosmeder , J. W., II; Park, E. J.; Lee, S. K.; Cuendet, M.; Gills, J.; Bhat, K.; Grubjesic, S.; Park, H.-S.; Mata-Greenwood, E.; Tan, Y. M.; Yu, R.; Lantvit, D. D.; Kinghorn, A. D. Characterization of natural product chemopreventive agents. In: Cancer Chemoprevention, Volume 2; Strategies for Cancer Chemoprevention; Kelloff, G. J., Hawk, E. T., Sigman, C. C., Eds.; Humana Press Inc.: Totowa, NJ, 2005; pp 3-37.
3. Proceedings of a Conference Exploring the Power of Phytochemicals: Research Advances on Grape Compounds; Pezzuto, J. M., Steele, V., Eds.; Swets and Zeitlinger: Lisse, The Netherlands, 1998; pp 80 (a supplement of Pharm. Biol.).
4. Bhat, K. P. L.; Kosmeder, J. W.; Pezzuto, J. M. Biological effects of resveratrol. Antioxid. Redox. Signaling 2001, 3, 1041-1064.
5. Subbaramaiah, K.; Chung, W. J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273, 21875-21882.
6. Jang, M.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol. Drugs Exp. Clin. Res. 1999, 25, 65-77.
7. Bhat, K. P.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol. Ann. N.Y. Acad. Sci. 2002, 957, 210-229.
8. Pezzuto, J. M.; Kondratyuk, T.; Shalaev, E. Cancer chemoprevention by wine polyphenols and resveratrol. In Carcinogenic and Anticarcinogenic Food Components; Baer-Dubowska, W., Bartoszek, A., Malejka-Giganti, D., Eds.; CRC Press: Boca Raton, FL, 2006; pp 239-282.
9. Bagchi, D. Resveratrol and Human Health; McGraw Hill: Columbus, OH, 2000.
10. Aggarwal, B.; Shishodia, S. Resveratrol in Health and Disease; Taylor & Francis: Boca Raton, FL, 2006.
11. Iriti, M.; Rossoni, M.; Faoro, F. Melatonin content in grape: myth or panacea. J. Sci. Food Agric. 2006, 86, 1432-1438.
12. Bradamante, S.; Barenghi, L.; Villa, A. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 2004, 22, 169-88.
13. Dell'Agli, M.; Busciala, A.; Bosisio, E. Vascular effects of wine polyphenols. Cardiovasc. Res. 2004, 63, 593-602.
14. Curin, Y.; Andriantsitohaina, R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol. Rep. 2005, 57 (Suppl.), 97-107.
15. Cordova, A. C.; Jackson, L. S.; Berke-Schlessel, D. W.; Sumpio, B. E. The cardiovascular protective effect of red wine. J. Am. Coll. Surg. 2005, 200, 428-439.
16. Pearson, D. A.; Holt, R. R.; Rein, D.; Paglieroni, T.; Schmitz, H. H.; Keen, C. L. Flavanols and platelet reactivity. Clin. Dev. Immunol. 2005, 12, 1-9.
17. Rasmussen, S. E.; Frederiksen, H.; Struntze Krogholm, K.; Poulsen, L. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol. Nutr. Food. Res. 2005, 49, 159-174.
18. Zern, T. L.; Wood, R. J.; Greene, C.; West, K. L.; Liu, Y.; Aggarwal, D.; et al. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J. Nutr. 2005, 135, 1911-1917.
19. Perez-Vizcaino, F.; Duarte, J.; Andriantsitohaina, R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res. 2006, 40, 1054-1065.
20. Holt, R. R.; Actis-Goretta, L.; Momma, T. Y.; Keen, C. L. Dietary flavanols and platelet reactivity. J. Cardiovasc. Pharmacol. 2006, 47 (Suppl. 2), S187-196.
21. de Lange, D. W.; Scholman, W. L.; Kraaijenhagen, R. J.; Akkerman, J. W.; van de Wiel, A. Alcohol and polyphenolic grape extract inhibit platelet adhesion in flowing blood. Eur. J. Clin. Invest. 2004, 34, 818-824.
22. Seymour, E. M.; Singer, A. A. M.; Kirakosyan, A.; Kaufman, P. B.; Bolling, S. F. Grape-enriched diets reduce cardiac and renal impairment during experimental heart failure pathogenesis. Presented at the Second International Symposium on Human Health Effects of Fruits and Vegetables; Houston, TX, October 9-13, 2007.
23. Pace-Asciak, C. R.; Rounova, O.; Hahn, S. E.; Diamandis, E. P.; Goldberg, D. M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta 1996, 246, 163-182.
24. Folts, J. Antithrombotic potential of grape juice and red wine for preventing heart attacks. Pharm. Biol. 1998, 36, 21.
25. Keevil, J. G.; Osman, H. E.; Reed, J. D.; Folts, J. D. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J. Nutr. 2000, 130, 53-56.
26. Freedman, J. E.; Parker, C., 3rd.; Li, L.; Perlman, J. A.; Frei, B.; Ivanov, V.; et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001, 103, 2792-2798.
27. Stein, J. H.; Keevil, J. G.; Wiebe, D. A.; Aeschlimann, S.; Folts, J. D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999, 100, 1050-1055.
28. Lekakis, J.; Rallidis, L. S.; Andreadou, I.; Vamvakou, G.; Kazantzoglou, G.; Magiatis, P.; et al. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 2005, 12, 596-600.
29. Coimbra, S. R.; Lage, S. H.; Brandizzi, L.; Yoshida, V.; da Luz, P. L. The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients. Braz. J. Med. Biol. Res. 2005, 38, 1339-1347.
30. Park, Y. K.; Kim, J. S.; Kang, M. H. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors 2004, 22, 145-147.
31. Hansen, A. S.; Marckmann, P.; Dragsted, L. O.; Finne Nielsen, I. L.; Nielsen, S. E.; Gronbaek, M. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur. J. Clin. Nutr. 2005, 59, 449-455.
32. Castilla, P.; Echarri, R.; Davalos, A.; Cerrato, F.; Ortega, H.; Teruel, J. L.; et al. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am. J. Clin. Nutr. 2006, 84, 252-262.
33. Aggarwal, B. B.; Bhardwaj, A.; Aggarwal, R. S.; Seeram, N. P.; Shishodia, S.; Takada, Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004, 24, 2783-2840.
34. Wolter, F.; Ulrich, S.; Stein, J. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines. J. Nutr. 2004, 134, 3219-3222.
35. Ulrich, S.; Wolter, F.; Stein, J. M. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol. Nutr. Food Res. 2005, 49, 452-461.
36. Oak, M. H.; El Bedoui, J.; Schini-Kerth, V. B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem. 2005, 16, 1-8.
37. Holcombe, R. F.; Stamos, M.; Hope, C.; Planutis, K.; Nguyen, A. V.; Crase, A.; Freeze dried grape powder inhibits a panel of Wnt pathway target genes in normal colonic mucosa: results of a pilot trial in patients with colon cancer. Presented at the Society for Integrative Oncology's Fourth International Conference on Expanding Horizons in Collaborative Cancer Care, San Francisco, CA, Nov 15-17, 2007.
38. Durak, I.; Karaca, L.; Cimen, M. B.; Kacmaz, M.; Avci, A.; Gubat, G.; et al. Dried white grapes enhance blood antioxidant potential. Nutr. Metab. Cardiovasc. Dis. 2002, 12, 204-205.
39. Park, Y. K.; Park, E.; Kim, J. S.; Kang, M. H. Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Koreans. Mutat. Res. 2003, 529, 77-86.
40. Ko, S. H.; Choi, S. W.; Ye, S. K.; Cho, B. L.; Kim, H. S.; Chung, M. H. Comparison of the antioxidant activities of nine different fruits in human plasma. J. Med. Food 2005, 8, 41-46.
41. Prior, R. L.; Gu, L.; Wu, X.; Jacob, R. A.; Sotoudeh, G.; Kader, A. A.; et al. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J. Am. College Nutr. 2007, 26, 170-181.
42. Kapadia, G. J.; Azuine, M. A.; Tokuda, H.; Takasaki, M.; Mukainaka, T.; Konoshima, T.; et al. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 2002, 45, 499-505.
43. Aziz, M. H.; Afaq, F.; Ahmad, N. Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochem. Photobiol. 2005, 81, 25-31.
44. Reagan-Shaw, S.; Afaq, F.; Aziz, M. H.; Ahmad, N. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 2004, 23, 5151-5160.
45. Adhami, V. M.; Afaq, F.; Ahmad, N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia 2003, 5, 74-82.
46. Afaq, F.; Adhami, V. M.; Ahmad, N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 2003, 186, 28-37.
47. Bhat, K. P.; Lantvit, D.; Christov, K.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001, 61, 7456-7463.
48. Khanduja, K. L.; Bhardwaj, A.; Kaushik, G. Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2004, 50, 61-65.
49. Walle, T.; Walle, U. K.; Sedmera, D.; Klausner, M. Benzo[a]pyrene- induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue. Drug Metab. Dispos. 2006, 34, 346-350.
50. Hebbar, V.; Shen, G.; Hu, R.; Kim, B. R.; Chen, C.; Korytko, P. J.; et al. Toxicogenomics of resveratrol in rat liver. Life Sci. 2005, 76, 2299-2314.
51. Sale, S.; Verschoyle, R. D.; Boocock, D.; Jones, D. J.; Wilsher, N.; Ruparelia, K. C.; et al. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br. J. Cancer 2004, 90, 736-144.
52. Lee, E. O.; Lee, H. J.; Hwang, H. S.; Ahn, K. S.; Chae, C.; Kang, K. S.; et al. Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 2006, 27, 2059-2069.
53. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E., Jr.; Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
54. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003, 72, 2219-2233.
55. Asensi, M.; Medina, I.; Ortega, A.; Carretero, J.; Bano, M. C.; Obrador, E.; et al. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 2002, 33, 387-398.
56. Revel, A.; Raanani, H.; Younglai, E.; Xu, J.; Rogers, I.; Han, R.; et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 2003, 23, 255-261.
57. Berge, G.; Ovrebo, S.; Eilertsen, E.; Haugen, A.; Mollerup, S. Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. Br. J. Cancer 2004, 91, 1380-1383.
58. Hecht, S. S.; Kenney, P. M.; Wang, M.; Trushin, N.; Agarwal, S.; Rao, A. V.; et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett. 1999, 137, 123-130.
59. Kimura, Y.; Okuda, H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinomabearing mice. J. Nutr. 2001, 131, 1844-1849.
60. Chen, J. C.; Chen, Y.; Lin, J. H.; Wu, J. M.; Tseng, S. H. Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound. Anticancer Res. 2006, 26, 1237-1245.
61. Garvin, S.; Ollinger, K.; Dabrosin, C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 2006, 231, 113-22.
62. Mousa, S. S.; Mousa, S. S.; Mousa, S. A. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr. Cancer 2005, 52, 59-65.
63. Min/+ mice. J. Nutr. 2004, 134, 5-10.
64. Schneider, Y.; Duranton, B.; Gosse, F.; Schleiffer, R.; Seiler, N.; Raul, F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr. Cancer 2001, 39, 102-107.
65. CIP expression. Carcinogenesis 2000, 21, 1619-1622.
66. Sengottuvelan, M.; Viswanathan, P.; Nalini, N. Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 2006, 27, 1038-1046.
67. Sato, M.; Pei, R. J.; Yuri, T.; Danbara, N.; Nakane, Y.; Tsubura, A. Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Lett. 2003, 202, 137-145.
68. Banerjee, S.; Bueso-Ramos, C.; Aggarwal, B. B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002, 62, 4945-4954.
69. Whitsett, T.; Carpenter, M.; Lamartiniere, C. A. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J. Carcinog. 2006, 5, 15.
70. Provinciali, M.; Re, F.; Donnini, A.; Orlando, F.; Bartozzi, B.; Di Stasio, G.; et al. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int. J. Cancer 2005, 115, 36-45.
71. Li, Z. G.; Hong, T.; Shimada, Y.; Komoto, I.; Kawabe, A.; Ding, Y.; et al. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 2002, 23, 1531-1536.
72. Wu, S. L.; Sun, Z. J.; Yu, L.; Meng, K. W.; Qin, X. L.; Pan, C. E. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J. Gastroenterol. 2004, 10, 3048-3052.
73. Rezk, Y. A.; Balulad, S. S.; Keller, R. S.; Bennett, J. A. Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. Am. J. Obstet. Gynecol. 2006, 194, e23-26.
74. Bove, K.; Lincoln, D. W.; Tsan, M. F. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 2002, 291, 1001-1005.
75. Gao, X.; Xu, Y. X.; Divine, G.; Janakiraman, N.; Chapman, R. A.; Gautam, S. C. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J. Nutr. 2002, 132, 2076-2081.
76. Yu, L.; Sun, Z. J.; Wu, S. L.; Pan, C. E. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J. Gastroenterol. 2003, 9, 2341-2343.
77. Miura, D.; Miura, Y.; Yagasaki, K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 2003, 73, 1393-1400.
78. Carbo, N.; Costelli, P.; Baccino, F. M.; Lopez-Soriano, F. J.; Argiles, J. M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 1999, 254, 739-743.
79. Liu, H. S.; Pan, C. E.; Yang, W.; Liu, X. M. Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J. Gastroenterol. 2003, 9, 1474-1476.
80. Chen, Y.; Tseng, S. H.; Lai, H. S.; Chen, W. J. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 2004, 136, 57-66.
81. Mishima, S.; Matsumoto, K.; Futamura, Y.; Araki, Y.; Ito, T.; Tanaka, T.; et al. Antitumor effect of stilbenoids from Vateria indica against allografted sarcoma S-180 in animal model. J. Exp. Ther. Oncol. 2003, 3, 283-288.
82. Mouria, M.; Gukovskaya, A. S.; Jung, Y.; Buechler, P.; Hines, O. J.; Reber, H. A.; et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 2002, 98, 761-769.
83. Li, T.; Sheng, L.; Fan, G. X.; Yuan, Y. K.; Li, T. Preliminary study on anti-tumor function of resveratrol and its immunological mechanism. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2005, 21, 575-579.
84. Zhou, H. B.; Chen, J. J.; Wang, W. X.; Cai, J. T.; Du, Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J. Gastroenterol. 2005, 11, 280-284.
85. Zamora-Ros, R.; Urpi-Sarda, M.; Lamuela-Raventos, R. M.; Estruch, R.; Vazquez-Agell, M.; Serrano-Martinez, M.; et al. Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption. Clin. Chem. 2006, 52, 1373-1380.
86. Boocock, D. J.; Faust, G. E.; Patel, K. R.; Schinas, A. M.; Brown, V. A.; Ducharme, M. P.; et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1246-1252.
87. http://clinicaltrials.gov/ (accessed Feb 14, 2008).
88. Agartan, C.; Whitbeck, C.; Chichester, P.; Levin, R. Effect of ethanol on protection of urinary bladder function by grape suspensions. Urology 2005, 66, 213-217.
89. Lin, A.; Mannitkarottu, A.; Chaudhry, A.; Whitbeck, C.; Kogan, B.; Chichester, P.; et al. Protective effects of grape suspension on in vivo ischaemia/reperfusion of the rabbit bladder. BJU Int. 2005, 96, 1397-1402.
90. Lin, A.; Mannikarottu, A.; Kogan, B.; Whitbeck, C.; Leggett, R.; Levin, R. Effect of bilateral in vivo ischemia/reperfusion on the activities of superoxide dismutase and catalase: response to a standardized grape suspension. Mol. Cell Biochem. 2007, 296, 11-16.
91. Girman, C.; Guess, H. Epidemiology of benign prostactic hyperplasia. In Prostatic Diseases; Lepor, H., Ed.; W.B. Saunders Co.: Philadelphia, 2000; pp 116-126.
92. American Cancer Society Cancer Facts & Figures 2007; American Cancer Society; Atlanta, 2007.
93. Klein, R.; Liverman, C.; Carlson, S.; Berman, N. Grape-enriched diet upregulates transthyretin in aged mouse brain: potential protection from Alzheimer's disease? Society for Neuroscience 2007 Annual Meeting; San Diego, CA; November 3-7, 2007 (Program Poster: 256.17/N27).
94. Buryanovskyy, L.; Fu, Y.; Boyd, M.; Ma, Y.; Hsieh, T.; Wu, J.; et al. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 2004, 43, 11417-11426.
95. Bertelli, A. Modulatory effect of resveratrol, a natural phytoalexin, on endothelial adhesion molecules and intracellular signal transduction. Pharm. Biol. 1998, 36, 44-52.
96. Creasy, L.; Coffee, M. Phytoalexin production potential of grape berries. J. Am. Soc. Hortic. Sci. 1998, 113, 230.
97. Schwekendiek, A.; Pfeffer, G.; Kindl, H. Pine stilbene synthase cDNA, a tool for probing environmental stress. FEBS Lett. 1992, 301, 41-44.
98. Jeandet, P.; Douillet-Breuil, A. C.; Bessis, R.; Debord, S.; Sbaghi, M.; Adrian, M. Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J. Agric. Food Chem. 2002, 50, 2731-2741.
99. Fumagalli, F.; Rossoni, M.; Iriti, M.; di Gennaro, A.; Faoro, F.; Borron, E.; Borgo, M.; Scienza, A.; Sala, A.; Folco, G. From field to health: a simple way to increase the nutraceutical content of grape as shown by NO-dependent vascular relaxation. J. Agric. Food Chem. 2006, 54, 5344-5349.
100. Hain, R.; Reif, H. J.; Krause, E.; Langebartels, R.; Kindl, H.; Vornam, B.; et al. Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 1993, 361, 153-156.
101. Hipskind, J. D.; Paiva, N. L. Constitutive accumulation of a resveratrol-glucoside in transgenic alfalfa increases resistance to Phoma medicaginis. Mol. Plant-Microbe Interact. 2000, 13, 551-562.